Patent · US Active

Combination therapy and kit for the prevention and treatment of cystic fibrosis

US9333235B2 · kind B2 · utility

1Cited by

1References

11Claims

0Family size

Assignee

TRUSTEES OF DARTMOUTH COLLEGE · US

Inventors

Dean R. Madden · Hanover, US
Patrick R. Cushing · Hanover, US
Prisca Boisguerin · St-Estève, FR
Rudolf Volkmer · Prenzlau, DE
Lars Vouilleme · Berlin, DE

Key dates

Filing date	Dec 13, 2013
Grant date	May 10, 2016
Priority date	—
Expiry date	Dec 13, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/4703
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination therapy and kit including an agent that inhibit the interaction between CAL and mutant CFTR proteins, in combination with a CFTR corrector, CFTR potentiator, mucolytic, anti-inflammatory agent or a combination thereof are provided as is a method for preventing or treating cystic fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.